Record Display for the EPA National Library Catalog


OLS Field Name OLS Field Data
Main Title Toxicological Review of Decabromodiphenyl Ether (BDE-209) (CAS No. 1163-19-5). In Support of Summary Information on the Integrated Risk Information System (IRIS).
CORP Author Environmental Protection Agency, Washington, DC. National Center for Environmental Assessment.
Year Published 2008
Report Number EPA/635/R-07/008F
Stock Number PB2008-114293
Additional Subjects Toxicology ; Ethers ; Risk assessments ; Toxicokinetics ; Absorption ; Distribution ; Pathology ; Neoplasms ; Metabolism ; Hazard identification ; Bioassays ; Cancer assessments ; Carcinogenesis ; Elimination ; Decabromodiphenyl ether ; Ether/bis (pentabromo-phenyl) ; BDE-209 ; Dose-response assessments ; Inhalation reference concentration ; CAS No 116-19-5
Library Call Number Additional Info Location Last
NTIS  PB2008-114293 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 03/10/2010
Collation 126p
The purpose of this Toxicological Review is to provide scientific support and rationale for the hazard and dose-response assessment in IRIS pertaining to chronic exposure to decabromodiphenyl ether. It is not intended to be a comprehensive treatise on the chemical or toxicological nature of decabromodiphenyl ether (BDE-209). This health assessment deals with BDE-209 of relatively high purity (=94%) and does not deal with earlier commercial decabromodiphenyl ether mixtures containing lower proportions of decabromodiphenyl ether (e.g., 75% purity). In addition to BDE-209, IRIS health assessments have also been prepared for three other polybrominated diphenyl ether congeners: tetraBDE-47, pentaBDE-99, and hexaBDE-153. These four congeners are those for which toxicological studies suitable for dose-response assessments were available and are the ones most commonly found in the environment and human biological media. The intent of Section 6, Major Conclusions in the Characterization of Hazard and Dose Response, is to present the major conclusions reached in the derivation of the reference dose, reference concentration and cancer assessment, where applicable, and to characterize the overall confidence in the quantitative and qualitative aspects of hazard and dose response by addressing the quality of data and related uncertainties. The discussion is intended to convey the limitations of the assessment and to aid and guide the risk assessor in the ensuing steps of the risk assessment process.